Therapeutic potential of hen egg white peptides for the treatment of intestinal inflammation

Journal of Functional Foods

Volumn 1, Issue 2, 2009, Pages 161-169

  Lee, Maggie ^a   Kovacs Nolan, Jennifer ^a   Archbold, Tania ^a   Fan, Ming Z ^a   Juneja, Lekh R ^b   Okubo, Tutomu ^b   Mine, Yoshinori ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b TAIYO KAGAKU CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SUS;

EID: 64349092094     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2009.01.005     Document Type: Article

References (61)

1. Al-Sadi R., Ye D., Dokladny K., and Ma T.Y. Mechanism of IL-1beta-induced increase in intestinal epithelial tight junction permeability. Journal of Immunology 180 (2008) 5653-5661
2. Atreya R., and Neurath M.F. New therapeutic strategies for treatment of inflammatory bowel disease. Mucosal Immunology 1 (2008) 175-182
3. Autschbach F., Braunstein J., Helmke E., Zuna I., Schurmann G., Niemir Z.I., Wallich R., Otto H.F., and Meuer S.C. In situ expression of interleukin-10 in noninflamed human gut and in inflammatory bowel disease. American Journal of Pathology 153 (1998) 121-130
4. Bassaganya-Riera J., and Hontecillas R. CLA and n-3 PUFA differentially modulate clinical activity and colonic PPAR-responsive gene expression in a pig model of experimental IBD. Clinical Nutrition 25 (2006) 454-465
5. Begue B., Wajant H., Bambou J.C., Duouquoy L., Siegmund D., Beaulieu J.F., Canioni D., Berrebi D., Brousse N., Desreumaux P., Schmitz J., Lentz M.J., Goulet O., Cerf-Bensussan N., and Ruemmele F.M. Implication of TNF-related apoptosis-inducing ligand in inflammatory intestinal epithelial lesions. Gastroenterology 130 (2006) 1962-1974
6. Bento A.F., Leite D.F., Claudino R.F., Hara D.B., Leal P.C., and Calixto J.B. The selective nonpeptide CXCR2 antagonist SB225002 ameliorates acute experimental colitis in mice. Journal of Leukocyte Biology 84 (2008) 1213-1221
7. Blennerhassett M.G., Bovell F.M., Lourenssen S., and McHugh K.M. Characteristics of inflammation-induced hypertrophy of rat intestinal smooth muscle cell. Digestive Diseases and Sciences 44 (1999) 1265-1272
8. Blennerhassett M.G., Vignjevic P., Vermillion D.L., and Collins S.M. Inflammation causes hyperplasia and hypertrophy in smooth muscle of rat small intestine. American Journal of Physiology 262 (1992) G1041-G1046
9. Cho J.Y., Chang H.J., Lee S.K., Kim H.J., Hwang J.K., and Chun H.S. Amelioration of dextran sulfate sodium-induced colitis in mice by oral administration of beta-caryophyllene, a sesquiterpene. Life Sciences 80 (2007) 932-939
10. Clayburgh D.R., Shen L., and Turner J.R. A porous defense: The leaky epithelial barrier in intestinal disease. Laboratory Investigation 84 (2004) 282-291
11. Daig R., Andus T., Aschenbrenner E., Falk W., Scholmerich J., and Gross V. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut 38 (1996) 216-222
12. Dieleman L.A., Ridwan B.U., Tennyson G.S., Beagley K.W., Bucy R.P., and Elson C.O. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 107 (1994) 1643-1652
13. Egger B., Bajaj-Elliott M., MacDonald T.T., Inglin R., Eysselein V.E., and Buchle M.W. Characterisation of acute murine dextran sodium sulphate colitis: Cytokine profile and dose dependency. Digestion 62 (2000) 240-248
14. Etchevers M.J., Aceituno M., and Sans M. Are we giving azathioprine too late? The case for early immunomodulation in inflammatory bowel disease. World Journal of Gastroenterology 14 (2008) 5512-5518
15. Fiorentino D.F., Zlotnik A., Mosmann T.R., Howard M., and O'Garra A. IL-10 inhibits cytokine production by activated macrophages. Journal of Immunology 147 (1991) 3815-3822
16. Garside P. Cytokines in experimental colitis. Clinical and Experimental Immunology 118 (1999) 337-339
17. Graefe H., Gutschow B., Gehring H., and Dibbelt L. Sensitive and specific photometric determination of mannitol in human serum. Clinical Chemistry and Laboratory Medicine 41 (2003) 1049-1055
18. Graham M.F., Diegelmann R.F., Elson C.O., Lindblad W.J., Gotschalk N., Gay S., and Gay R. Collagen content and types in the intestinal strictures of Crohn's disease. Gastroenterology 94 (1988) 257-265
19. Ito R., Kita M., Shin-Ya M., Kishida T., Urano A., Takada R., Sakagami J., Imanishi J., Iwakura Y., Okanoue T., Yoshikawa T., Kataoka K., and Mazda O. Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice. Biochemical and Biophysical Research Communications 377 (2008) 12-16
20. Ivanov I.I., Zhou L., and Littman D.R. Transcriptional regulation of Th17 cell differentiation. Seminars in Immunology 19 (2007) 409-417
21. Kaiko G.E., Horvat J.C., Beagley K.W., and Hansbro P.M. Immunological decision-making: How does the immune system decide to mount a helper T-cell response?. Immunology 123 (2008) 326-338
22. Kappelman M.D., Rifas-Shiman S.L., Porter C., Ollendorf D.A., Sandler R.S., Galanko J.A., and Finkelstein J.A. Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology 135 (2008) 1907-1913
23. Kitajima S., Takuma S., and Morimoto M. Changes in colonic mucosal permeability in mouse colitis induced with dextran sulfate sodium. Experimental Animals 48 (1999) 137-143
24. Klein S., Meyers S., O'Sullivan P., Barton D., Leleiko N., and Janowitz H.D. The metabolic impact of active ulcerative colitis. Energy expenditure and nitrogen balance. Journal of Clinical Gastroenterology 10 (1988) 34-40
25. Kovacs-Nolan J., Phillips M., and Mine Y. Advances in the value of eggs and egg components for human health. Journal of Agricultural and Food Chemistry 53 (2005) 8421-8431
26. Kucharzik T., Stoll R., Lugering N., and Domschke W. Circulating anti-inflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD). Clinical and Experimental Immunology 100 (1995) 452-456
27. Kwon K.H., Murakami A., Tanaka T., and Ohigashi H. Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: Attenuation of pro-inflammatory gene expression. Biochemical Pharmacology 69 (2005) 395-406
28. Li-Chan E.C.Y., Powrie W.D., and Nakai S. The chemistry of eggs and egg products. In: Stadelman W.J., and Cotterill O.J. (Eds). Egg science and technology. 4th ed. (1995), Haworth Press, New York 105-175
29. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 (2001) 402-408
30. Lovato P., Brender C., Agnholt J., Kelsen J., Kaltoft K., Svejgaard A., Eriksen K.W., Woetmann A., and Odum N. Constitutive STAT3 activation in intestinal T cells from patients with Crohn's disease. Journal of Biological Chemistry 278 (2003) 16777-16781
31. Lunn P.G., Northrop C.A., and Northrop A.J. Automated enzymatic assays for the determination of intestinal permeability probes in urine. 2. Mannitol. Clinica Chimica Acta 183 (1989) 163-170
32. MacDermott R.P. Alterations of the mucosal immune system in inflammatory bowel disease. Journal of Gastroenterology 31 (1996) 907-916
33. Mackenzie M.L., Warren M.R., and Wykes L.J. Colitis increases albumin synthesis at the expense of muscle protein synthesis in macronutrient-restricted piglets. Journal of Nutrition 133 (2003) 1875-1881
34. McGuckin M.A., Eri R., Simms L.A., Florin T.H., and Radford-Smith G. Intestinal barrier dysfunction in inflammatory bowel diseases. Inflammatory Bowel Disease 15 (2009) 100-113
35. Melgar S., Karlsson A., and Michaelsson E. Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: Correlation between symptoms and inflammation. American Journal of Physiology. Gastrointestinal and Liver Physiology 288 (2005) G1 328-G1 338
36. Miller E.R., and Ullrey D.E. The pig as a model for human nutrition. Annual Review of Nutrition 7 (1987) 361-382
37. Mine Y., and D'Silva I. Bioactive components in egg white. In: Mine Y. (Ed). Egg bioscience and biotechnology (2008), John Wiley and Sons, New York 141-184
38. Mizoguchi A., and Mizoguchi E. Inflammatory bowel disease, past, present and future: Lessons from animal models. Journal of Gastroenterology 43 (2008) 1-17
39. Mudter J., and Neurath M.F. Il-6 signaling in inflammatory bowel disease: Pathophysiological role and clinical relevance. Inflammatory Bowel Disease 13 (2007) 1016-1023
40. Musso A., Dentelli P., Carlino A., Chiusa L., Repici A., Sturm A., Fiocchi C., Rizzetto M., Pegoraro L., Sategna-Guidetti C., and Brizzi M.F. Signal transducers and activators of transcription 3 signaling pathway: An essential mediator of inflammatory bowel disease and other forms of intestinal inflammation. Inflammatory Bowel Disease 11 (2005) 91-98
41. Nielsen O.H., Koppen T., Rudiger N., Horn T., Eriksen J., and Kirman I. Involvement of interleukin-4 and -10 in inflammatory bowel disease. Digestive Diseases and Sciences 41 (1996) 1786-1793
42. Pellegrini A., Thomas U., Wild P., Schraner E., and von Fellenberg R. Effect of lysozyme or modified lysozyme fragments on DNA and RNA synthesis and membrane permeability of Escherichia coli. Microbiological Research 155 (2000) 69-77
43. Podolsky D.K. Inflammatory bowel disease. New England Journal of Medicine 347 (2002) 417-429
44. Rigaud D., Angel L.A., Cerf M., Carduner M.J., Melchior J.C., Sautier C., Rene E., Apfelbaum M., and Mignon M. Mechanisms of decreased food intake during weight loss in adult Crohn's disease patients without obvious malabsorption. American Journal of Clinical Nutrition 60 (1994) 775-781
45. Rozen S., and Skaletsky H.J. Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S., and Misener S. (Eds). Bioinformatics methods and protocols: Methods in molecular biology (2000), Humana Press, Totowa 365-386
46. Saro C., and Sicilia B. Inflammatory bowel diseases: A disease (s) of modern times? Is incidence still increasing?. World Journal of Gastroenterology 14 (2008) 5491-5498
47. Sartor R.B. Cytokines in intestinal inflammation: Pathophysiological and clinical considerations. Gastroenterology 106 (1994) 533-539
48. Scaldaferri F., and Fiocchi C. Inflammatory bowel disease: Progress and current concepts of etiopathogenesis. Journal of Digestive Diseases 8 (2007) 171-178
49. Shanahan F. Inflammatory bowel disease: Immunodiagnostics, immunotherapeutics, and ecotherapeutics. Gastroenterology 120 (2001) 622-635
50. Tai E.K., Wu W.K., Wong H.P., Lam E.K., Yu L., and Cho C.H. A new role for cathelicidin in ulcerative colitis in mice. Experimental Biology and Medicine (Maywood) 232 (2007) 799-808
51. Tanizaki H., Tanaka H., Iwata H., and Kato A. Activation of macrophages by sulfated glycopeptides in ovomucin, yolk membrane, and chalazae in chicken eggs. Bioscience, biotechnology, and biochemistry 61 (1997) 1883-1889
52. Tezuka, H., & Yoshikawa, M. (1995). In Annual meeting of the Japan society for bioscience, biotechnology, and agrochemistry (p. 163). Tokyo, Japan.
53. Thymann T., Burrin D.G., Tappenden K.A., Bjornvad C.R., Jensen S.K., and Sangild P.T. Formula-feeding reduces lactose digestive capacity in neonatal pigs. British Journal of Nutrition 95 (2006) 1075-1081
54. Tomoyose M., Mitsuyama K., Ishida H., Toyonaga A., and Tanikawa K. Role of interleukin-10 in a murine model of dextran sulfate sodium-induced colitis. Scandinavian Journal of Gastroenterology 33 (1998) 435-440
55. Torres M.I., and Rios A. Current view of the immunopathogenesis in inflammatory bowel disease and its implications for therapy. World Journal of Gastroenterology 14 (2008) 1972-1980
56. Umehara Y., Kudo M., Nakaoka R., Kawasaki T., and Shiomi M. Serum proinflammatory cytokines and adhesion molecules in ulcerative colitis. Hepatogastroenterology 53 (2006) 879-882
57. Van der Sluis M., De Koning B.A., De Bruijn A.C., Velcich A., Meijerink J.P., Van Goudoever J.B., Buller H.A., Dekker J., Van Seuningen I., Renes I.B., and Einerhand A.W. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 131 (2006) 117-129
58. Wang F., Graham W.V., Wang Y., Witkowski E.D., Schwarz B.T., and Turner J.R. Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. American Journal of Pathology 166 (2005) 409-419
59. Wirtz S., Neufert C., Weigmann B., and Neurath M.F. Chemically induced mouse models of intestinal inflammation. Nature Protocols 2 (2007) 541-546
60. Wirtz S., and Neurath M.F. Animal models of intestinal inflammation: New insights into the molecular pathogenesis and immunotherapy of inflammatory bowel disease. International Journal of Colorectal Disease 15 (2000) 144-160
61. Xavier R.J., and Podolsky D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448 (2007) 427-434